NervGen Pharma (9UA.F) Q3 2024 Earnings

22AugConfirmed
Q2 2024
Q3 2024
-0.07
-0.06
-0.04
-0.03

Details

Expected EPS
-0.059157764280000004
Actual EPS
-0.07230393412000001
Surprise EPS
-0.01
Surprise Percent
+22.22%

Description

NervGen Pharma (9UA.F) has reported earnings of -0.07230393412000001 per share for Q3 2024.

0 Comments

Share your thoughts